FDA Authorizes 11 Flavored Nicotine Pouches
The latest round of products brings the total number of FDA-authorized flavored nicotine pouches to 43.
The latest round of products brings the total number of FDA-authorized flavored nicotine pouches to 43.
The latest round of products brings the total number of FDA-authorized flavored nicotine pouches to 43.
Read MoreA new paper in JAMA provides the first US recommendations for clinicians on integrating nicotine e-cigarettes into smoking cessation plans.
Read MoreA Rutgers Health study indicates that capping nicotine levels could eliminate smoking disparities and provide a trillion-dollar boost to the US economy.
Read MoreA systematic review of 17 clinical trials found that smokers did not inhale more or smoke more cigarettes when using low-nicotine products.
Read MoreThere are now 30 flavored nicotine pouch products authorized for sale by the FDA, but some health organizations have expressed concerns for potential youth adoption.
Read MoreA smartphone-based program uses financial rewards to improve smoking cessation rates among pregnant individuals in rural areas.
Read MoreData from 2022 to 2025 indicate that current tobacco use, including e-cigarettes and cigarettes, has decreased among US middle and high school students.
Read MoreThe FDA authorized 20 Zyn nicotine pouches, including 10 flavored products, despite concerns from health experts over increased youth use.
Read MoreA study shows that tobacco-free “herbal” cigarettes produce high levels of fine particles and molecules that can damage lung tissue.
Read MoreA study of 142,000 patients suggests GLP-1 medications may influence brain pathways involved in cravings for nicotine, opioids, and alcohol.
Read MoreA study of more than 175,000 students found that teens consistently perceive cannabis as lower risk than nicotine products and alcohol, with perceived harm declining as students age.
Read MoreThe FDA authorized the marketing of four Glas electronic nicotine delivery systems (ENDS) through the premarket tobacco product application pathway.
Read More2019 was a turning point in youth vaping, as aggressive public health campaigns and extensive news coverage of e-cigarette or vaping product use-associated lung injury (EVALI) effectively curbed teen use.
Read MoreA study of over 92,000 incidents shows a 243% surge in e-cigarette exposures among toddlers, often involving direct inhalation from devices.
Read MoreA 2025 ban on disposable vapes in the United Kingdom may be pushing some users to smoke cigarettes instead, according to a youth survey.
Read MoreA Phase 1 clinical trial of Qnovia’s RespiRx handheld inhalable nicotine replacement therapy (NRT) revealed cigarette-comparable nicotine delivery with favorable safety profile.
Read MoreStatewide study finds students in funded schools were significantly less likely to smoke or vape than counterparts in schools without funding.
Read MoreAbstention from drug use remains at an historic high for teens, according to an annual survey of US adolescents.
Read MoreRutgers Health research confirms confusion about the different mechanisms that make nicotine and tobacco addictive.
Read MoreThe smoking cessation drug candidate cytisinicline significantly improved smoking quit rates compared to placebo in adults with and without COPD.
Read MoreNicotine pouch use has significantly increased, while vaping nicotine or cannabis were at all-time highs among American adults age 19-30 years old.
Read MoreThe first national estimate of daily nicotine pouch use in the US found that 2.5% of American adults use the product, and most users may be smokers who want to reduce or quit smoking.
Read MoreThe proliferation of nicotine pouch ingestions by children has prompted the FDA to call for child-resistant packaging for all products.
Read MoreYouth vaping is consistently linked to subsequent smoking, marijuana and alcohol use, and is associated with heightened risks of asthma, cough, injuries and mental ill health.
Read More